Procyanidin B-2 (Apple Polyphenol) for Androgenetic Alopecia

Verdict: Weak, disputed evidence for hair regrowth

Topical procyanidin B-2 (apple polyphenol) has only weak, disputed evidence for male androgenetic alopecia: a few small, positive early trials exist, but all come from one industry-funded team and have never been independently replicated. It is not an established hair-loss treatment.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

The grade rests on three small double-blind RCTs of a 1% topical tonic in Japanese men with AGA. They were directionally positive: the 2005 trial (PMID 17168871, n=43) reported 78.6% of treated men with increased hair count versus 9.1% on vehicle (p<0.001), and the 2001 trial (PMID 11406858, n=29) showed roughly +6 hairs/0.25 cm2 over placebo (p<0.001). An animal/mechanism study (PMID 11841365) proposed PKC-isozyme modulation, while the 2000 trial (PMID 11194183, n=29) gave similar results.

These signals are heavily discounted. Every human and mechanistic study comes from a single Takahashi-led group funded by Kyowa Hakko/Asahi, the apple-polyphenol supplier, with cumulative enrollment near 100 men, single-center, and zero independent replication in over 20 years. EFSA found that for proanthocyanidins 'a cause and effect relationship has not been established' (for circulatory/antioxidant claims), and the FDA recognizes apple polyphenol extract only as GRAS for food, not as a hair treatment.

No major clinical body (NIH ODS, Mayo, Cleveland Clinic, Harvard Health) or dermatology guideline (AAD, ISHRS, EADV) lists it for AGA, and the trials used a 1% topical tonic, so oral apple-polyphenol capsules cannot be assumed equivalent. Given a plausible mechanism but a thin, conflicted, unreplicated base, a weak and disputed grade is appropriate; finasteride and minoxidil remain the evidence-backed options.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.46
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
73%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L2 PubMedPrimary literature
0.60
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.464
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Investigation of the topical application of procyanidin oligomers from apples to identify their potential use as a hair-growing agent (Takahashi et al., AJCR)
PMID: 17168871 2005 RCT (double-blind) n = 43
Finding: 78.6% of procyanidin B-2 subjects showed an increase in mean hair count vs 9.1% on vehicle (p<0.001). Mean total hair count change favored treatment in male AGA subjects. Reported as the larger follow-up to Takahashi 2000/2001.
🟠 Limited quality ⚠️ Industry-funded Effect size: [object Object]
View on PubMed
The first clinical trial of topical application of procyanidin B-2 to investigate its potential as a hair growing agent (Takahashi et al., JID)
PMID: 11406858 2001 RCT (double-blind) n = 29
Finding: Treatment vs placebo: 78.9% vs 30.0% showed increased mean hair diameter (p<0.02); hair count +3.67±4.09 vs −2.54±4.00 hairs/0.25 cm² (p<0.001). Male AGA population.
🟠 Limited quality ⚠️ Industry-funded Effect size: [object Object]
View on PubMed
Investigation of topical application of procyanidin B-2 from apple to identify its potential use as a hair growing agent (Takahashi et al.)
PMID: 11194183 2000 RCT (double-blind) n = 29
Finding: Total hair: +6.68±5.53 (tx) vs +0.08±4.56 (placebo), p<0.005; terminal hair: +1.99±2.58 vs −0.82±3.40, p<0.02. Male AGA cohort.
🟠 Limited quality ⚠️ Industry-funded Effect size: [object Object]
View on PubMed
Procyanidin B-2, extracted from apples, promotes hair growth: a laboratory study (Kamimura & Takahashi)
PMID: 11841365 2002 Animal Study
Finding: Procyanidin B-2 down-regulates telogen-specific PKC isozymes and accelerates telogen→anagen transition in C3H mice. Provides the PKC mechanism cited throughout the Takahashi clinical series; also referenced as anti-PGD2-adjacent pathway in later reviews.
🟠 Limited quality ⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Apple polyphenol extract (Applephenon) is generally recognized as safe (GRAS) under the intended conditions of use as a food ingredient source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of proanthocyanidins from various sources and the maintenance of normal blood pressure / maintenance of normal blood flow / protection of body lipids from oxidative damage / maintenance of normal vascular function source↗
L4d TW TFDA / 衛福部
Neutral
本署公告之健康食品保健功效項目共十三項:護肝(針對化學性肝損傷)、抗疲勞、調節血脂、調節血糖、免疫調節、骨質保健、牙齒保健、延緩衰老、促進鐵吸收、胃腸功能改善、輔助調節血壓、不易形成體脂肪、輔助調整過敏體質。食品(含一般食品及健康食品)之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形,亦不得涉及醫療效能。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-androgenetic-alopecia-INT-procyanidin-b-2-001 繁體中文版 →